miR-222 has an oncogenic role in regulating cellular growth of human endometrial carcinoma by suppressing target gene estrogen receptor alpha (ERα) and thus, its overexpression promotes cell proliferation and inhibits apoptosis [39]. The gene discussed is ESR1; the disease is endometrial carcinoma.